{"entity":{"type":"insider","cik":"0001665000","url":"/insider/0001665000","json_url":"/insider/0001665000.json","name":"Gibbs Michael Terrence","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":12,"first":"2017-06-08","last":"2023-04-06","span_basis":"filed_date"},"name_variants":[{"name":"Gibbs Michael Terrence","source":"filing","n_filings":12,"first_seen":"2017-06-08","last_seen":"2023-04-06"}],"transactions":[{"id":7995205,"accession":"0000950170-23-012031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-012031","line_url":"/filing/0000950170-23-012031#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239.0,"shares_display":"239","price_per_share":0.481,"price_display":"0.48","price_state":"stated","total_value":114.959,"total_display":"114.96","shares_owned_after":6612.0,"shares_owned_after_display":"6,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-04-06","scope":"insider"},{"id":8620056,"accession":"0000899243-23-007725","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-007725","line_url":"/filing/0000899243-23-007725#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1585.0,"shares_display":"1,585","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":935.15,"total_display":"935.15","shares_owned_after":6517.0,"shares_owned_after_display":"6,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-09","scope":"insider"},{"id":8620052,"accession":"0000899243-23-007725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-007725","line_url":"/filing/0000899243-23-007725#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2145.0,"shares_display":"2,145","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":1394.25,"total_display":"1,394.25","shares_owned_after":5188.0,"shares_owned_after_display":"5,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-03-09","scope":"insider"},{"id":6364674,"accession":"0000899243-22-014416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-014416","line_url":"/filing/0000899243-22-014416#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":4900.0,"total_display":"4,900.00","shares_owned_after":166651.0,"shares_owned_after_display":"166,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-11","scope":"insider"},{"id":4867325,"accession":"0000899243-21-013462","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-013462","line_url":"/filing/0000899243-21-013462#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8758.0,"shares_display":"8,758","price_per_share":1.56,"price_display":"1.56","price_state":"stated","total_value":13662.48,"total_display":"13,662.48","shares_owned_after":73256.0,"shares_owned_after_display":"73,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-25","filed_date":"2021-03-25","scope":"insider"},{"id":5131110,"accession":"0000899243-21-007776","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-007776","line_url":"/filing/0000899243-21-007776#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7280.0,"shares_display":"7,280","price_per_share":2.06,"price_display":"2.06","price_state":"stated","total_value":14996.8,"total_display":"14,996.80","shares_owned_after":65347.0,"shares_owned_after_display":"65,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-23","scope":"insider"},{"id":2207137,"accession":"0000899243-20-005806","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005806","line_url":"/filing/0000899243-20-005806#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5808.0,"shares_display":"5,808","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":4762.56,"total_display":"4,762.56","shares_owned_after":60779.0,"shares_owned_after_display":"60,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-25","scope":"insider"},{"id":2100274,"accession":"0000899243-20-004327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-004327","line_url":"/filing/0000899243-20-004327#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":2464.0,"total_display":"2,464.00","shares_owned_after":56587.0,"shares_owned_after_display":"56,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"},{"id":2540953,"accession":"0000899243-20-003302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-003302","line_url":"/filing/0000899243-20-003302#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3283.0,"shares_display":"3,283","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":2889.04,"total_display":"2,889.04","shares_owned_after":53954.0,"shares_owned_after_display":"53,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-05","scope":"insider"},{"id":8339624,"accession":"0000899243-19-003310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-003310","line_url":"/filing/0000899243-19-003310#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3005.0,"shares_display":"3,005","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":10096.8,"total_display":"10,096.80","shares_owned_after":57237.0,"shares_owned_after_display":"57,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-11","filed_date":"2019-02-12","scope":"insider"},{"id":8757758,"accession":"0000899243-19-002640","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-002640","line_url":"/filing/0000899243-19-002640#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1820.0,"shares_display":"1,820","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":6315.4,"total_display":"6,315.40","shares_owned_after":54428.0,"shares_owned_after_display":"54,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-01","filed_date":"2019-02-05","scope":"insider"},{"id":8757755,"accession":"0000899243-19-002640","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-002640","line_url":"/filing/0000899243-19-002640#line-3","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":939.0,"shares_display":"939","price_per_share":3.35,"price_display":"3.35","price_state":"stated","total_value":3145.65,"total_display":"3,145.65","shares_owned_after":56248.0,"shares_owned_after_display":"56,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-31","filed_date":"2019-02-05","scope":"insider"},{"id":6619038,"accession":"0000899243-18-015718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-015718","line_url":"/filing/0000899243-18-015718#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2202.0,"shares_display":"2,202","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":9424.56,"total_display":"9,424.56","shares_owned_after":16911.0,"shares_owned_after_display":"16,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-09","filed_date":"2018-06-08","scope":"insider"},{"id":4363665,"accession":"0001104659-17-038154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-038154","line_url":"/filing/0001104659-17-038154#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001665000","owner_name":"Gibbs Michael Terrence","owner_url":"/insider/0001665000","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":3510.0,"total_display":"3,510.00","shares_owned_after":10431.0,"shares_owned_after_display":"10,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-08","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492674","name":"T2 Biosystems, Inc.","url":"/issuer/0001492674","role":"Officer (General Counsel)","n_filings":12,"first_seen":"2017-06-08","last_seen":"2023-04-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001665000","retrieved_at":"2026-08-21T15:22:18+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}